Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 440

Similar articles for PubMed (Select 21842265)

1.

Axl is a prognostic marker in oral squamous cell carcinoma.

Lee CH, Yen CY, Liu SY, Chen CK, Chiang CF, Shiah SG, Chen PH, Shieh YS.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S500-8. doi: 10.1245/s10434-011-1985-8. Epub 2011 Aug 13.

PMID:
21842265
2.

Carbonic anhydrase IX overexpression regulates the migration and progression in oral squamous cell carcinoma.

Yang JS, Lin CW, Chuang CY, Su SC, Lin SH, Yang SF.

Tumour Biol. 2015 Jul 1. [Epub ahead of print]

PMID:
26130414
3.

Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis.

da Silva SD, Marchi FA, Xu B, Bijian K, Alobaid F, Mlynarek A, Rogatto SR, Hier M, Kowalski LP, Alaoui-Jamali MA.

Oncotarget. 2015 Jun 15. [Epub ahead of print]

4.

Overexpressed tryptophanyl-tRNA synthetase, an angiostatic protein, enhances oral cancer cell invasiveness.

Lee CW, Chang KP, Chen YY, Liang Y, Hsueh C, Yu JS, Chang YS, Yu CJ.

Oncotarget. 2015 Jun 17. [Epub ahead of print]

5.

The Co-Expression of Kallikrein 5 and Kallikrein 7 Associates with Poor Survival in Non-HPV Oral Squamous-Cell Carcinoma.

Leusink FK, van Diest PJ, Frank MH, Broekhuizen R, Braunius W, van Hooff SR, Willems SM, Koole R.

Pathobiology. 2015 May 28;82(2):58-67. [Epub ahead of print]

PMID:
26022646
6.

Increased tumor cell expression of Axl is a marker of aggressive features in breast cancer among African women.

Ahmed L, Nalwoga H, Arnes JB, Wabinga H, Micklem DR, Akslen LA.

APMIS. 2015 May 25. doi: 10.1111/apm.12403. [Epub ahead of print]

PMID:
26011102
7.

Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.

Schrader CH, Kolb M, Zaoui K, Flechtenmacher C, Grabe N, Weber KJ, Hielscher T, Plinkert PK, Hess J.

Mol Cancer. 2015 May 20;14:107. doi: 10.1186/s12943-015-0381-6.

8.

Fractal analysis of nuclear histology integrates tumor and stromal features into a single prognostic factor of the oral cancer microenvironment.

Bose P, Brockton NT, Guggisberg K, Nakoneshny SC, Kornaga E, Klimowicz AC, Tambasco M, Dort JC.

BMC Cancer. 2015 May 15;15:409. doi: 10.1186/s12885-015-1380-0.

9.

Overexpression of pyruvate kinase M2 associates with aggressive clinicopathological features and unfavorable prognosis in oral squamous cell carcinoma.

Wang Y, Zhang X, Zhang Y, Zhu Y, Yuan C, Qi B, Zhang W, Wang D, Ding X, Wu H, Cheng J.

Cancer Biol Ther. 2015 Jun 3;16(6):839-45. doi: 10.1080/15384047.2015.1030551. Epub 2015 May 13.

PMID:
25970228
10.

Prognostic implication of the loss of TGFBR2 expression in oral carcinoma.

Sivadas VP, Saakshi G, Iype EM, Balan A, Kannan S.

Neoplasma. 2015;62(3):398-404.

PMID:
25967359
11.

AXL is an oncotarget in human colorectal cancer.

Martinelli E, Martini G, Cardone C, Troiani T, Liguori G, Vitagliano D, Napolitano S, Morgillo F, Rinaldi B, Melillo RM, Liotti F, Nappi A, Bianco R, Berrino L, Ciuffreda LP, Ciardiello D, Iaffaioli V, Botti G, Ferraiolo F, Ciardiello F.

Oncotarget. 2015 Apr 29. [Epub ahead of print]

12.

Glut-1 as a prognostic biomarker in oral squamous cell carcinoma.

Harshani JM, Yeluri S, Guttikonda VR.

J Oral Maxillofac Pathol. 2014 Sep-Dec;18(3):372-8. doi: 10.4103/0973-029X.151318.

13.

CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.

Zhang H, Zhang J, Nan X, Li X, Qu J, Hong Y, Sun L, Chen Y, Li T.

Tumour Biol. 2015 May 7. [Epub ahead of print]

PMID:
25946973
14.

Effects of AGBL2 on cell proliferation and chemotherapy resistance of gastric cancer.

Zhu H, Zheng Z, Zhang J, Liu X, Liu Y, Yang W, Liu Y, Zhang T, Zhao Y, Liu Y, Su X, Gu X.

Hepatogastroenterology. 2015 Mar-Apr;62(138):497-502.

PMID:
25916089
15.

Polarization of tumor-associated macrophages and Gas6/Axl signaling in oral squamous cell carcinoma.

Chiu KC, Lee CH, Liu SY, Chou YT, Huang RY, Huang SM, Shieh YS.

Oral Oncol. 2015 Jul;51(7):683-9. doi: 10.1016/j.oraloncology.2015.04.004. Epub 2015 Apr 21.

PMID:
25910588
16.

Growth differentiation factor 15 as a radiation-induced marker in oral carcinoma increasing radiation resistance.

Schiegnitz E, Kämmerer PW, Rode K, Schorn T, Brieger J, Al-Nawas B.

J Oral Pathol Med. 2015 Apr 16. doi: 10.1111/jop.12323. [Epub ahead of print]

PMID:
25880686
17.

CD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma.

Shakib PA, Ensani F, Abdirad A, Valizadeh B, Seyedmajidi M, Sum S.

Dent Res J (Isfahan). 2015 Mar-Apr;12(2):181-6.

18.

Prognostic implication of the loss of TGFBR2 expression in oral carcinoma.

Sivadas VP, Saakshi G, Iype EM, Balan A, Kannan S.

Neoplasma. 2015 Apr 13. doi: 10.4149/neo_2015_048. [Epub ahead of print]

PMID:
25866314
19.

Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.

Ni YH, Ding L, Zhang DY, Hou YY, Huang X, Hu Q.

Histopathology. 2015 Mar 30. doi: 10.1111/his.12703. [Epub ahead of print]

PMID:
25828894
20.

The prognostic value of histopathological grading systems in oral squamous cell carcinomas.

Sawazaki-Calone I, Rangel A, Bueno AG, Morais CF, Nagai HM, Kunz RP, Souza RL, Rutkauskis L, Salo T, Almangush A, Coletta RD.

Oral Dis. 2015 Mar 31. doi: 10.1111/odi.12343. [Epub ahead of print]

PMID:
25825335
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk